ELAB vs NFLX · rev $2.0M vs P/E 25, rev $12.56B
Elevai Labs, Inc. Common Stock (ELAB) versus Netflix Inc (NFLX) — a side-by-side from cached financials, not a winner call.
Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company listed on NASDAQ.
Netflix Inc (NFLX) is a entertainment company listed on NASDAQ.
Latest reported ELAB revenue for 2026-06-30 was $2.0M. Net income was -$7.9M. ELAB currently screens at market cap $6.5M.
Latest reported NFLX revenue for 2026-06-30 was $12.56B. Net income was $3.40B. Revenue was up 2.5% from 2026-03-31 to 2026-06-30. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
ELAB currently screens at market cap $6.5M. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
Not investment advice. Open the ELAB and NFLX stock pages for the full models.
Not investment advice.